Changes to the Life Healthcare Executive Committees LIFE HEALTHCARE GROUP HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number: 2003/002733/06) ISIN: ZAE000145892 Share Code: LHC ("Life Healthcare" or "the Group" or "the Company") LIFE HEALTHCARE FUNDING LIMITED (Incorporated in the Republic of South Africa) (Registration number 2016/273566/06) LEI: 3789SJPQJZF8ZYXTZ394 Bond company code: LHFI CHANGES TO THE LIFE HEALTHCARE EXECUTIVE COMMITTEES Shareholders and noteholders are advised that, following the disposal of the Alliance Medical Group ("AMG"), the Executive Committees ("Exco") of Life Healthcare have been combined and reconstituted. This has been done to consolidate capabilities and experience of the team to ensure the effective delivery of the Life Healthcare strategy. The reconstituted Exco will continue to be led by Peter Wharton-Hood as the the Chief Executive Officer. Important changes with effect from 3 April 2024, include the following: Pieter van der Westhuizen – Chief Financial Officer Pieter van der Westhuizen, will remain as Chief Financial Officer and will also assume responsibility for the Information Technology and Cyber porfolios. Adam Pyle – Chief Strategy and Growth Officer Adam Pyle moves from the role of Chief Executive southern Africa into the new role of Chief Strategy and Growth Officer where, he will take responsibility for the critical focus on southern Africa growth opportunities. These include renal dialysis, diagnostic imaging, nuclear medicine and oncology. Adam's portfolio will also incude stakeholder relations, new products, marketing and communication as well as investor relations. In addition, Adam will coordinate Life Healthcare's strategy. The Chief Strategy and Growth Officer is a critical role in delivering on the Company's future growth strategy. Craig Koekemoer - Chief Operations Officer Craig Koekemoer, who previously held the role of Business Operations Executive – SA, will take on the new role of Chief Operations Officer. Craig's many years of experience through the various acute hospital settings, makes him ideally suited to take on the role. These important changes ensure a smooth transition, retain key industry experience and will enable Life Healthcare to deliver on its strategy going forward. This will position the Company as a leading, diversified, and integrated healthcare services provider in southern Africa with clear capital allocation priorities, a resilient and sustainable financial profile, and a strong cash generation ability. For further information, please contact: Adam Pyle, Executive Head of Investor Relations investor.relations@lifehealthcare.co.za Dunkeld 11 April 2024 Equity and Debt Sponsor Rand Merchant Bank (a division of FirstRand Bank Limited) Date: 11-04-2024 10:15:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.